Functional Annotation Report: leuD (Q88LE7, PP_1986) in Pseudomonas putida KT2440

Gene/Protein Identity Verification

Before presenting the research, the target identity was verified against all mandatory checkpoints, and no ambiguity was found:

The gene symbol is unambiguous and the literature is directly relevant. The annotation below rests on experimental biochemistry in Salmonella/E. coli, X‑ray crystallography in Mycobacterium tuberculosis, iron–sulfur biochemistry in yeast, and curated database records (UniProt/HAMAP, KEGG, Rhea), transferred to the P. putida protein through high‑confidence orthology.

1. Summary (Answer to the Research Question)

leuD (Q88LE7, locus PP_1986) encodes the small subunit of isopropylmalate isomerase (IPMI; 3‑isopropylmalate dehydratase; EC 4.2.1.33), a 214‑residue polypeptide. It has no independent catalytic activity; instead it forms an obligate 1:1 heterodimer with the large subunit LeuC (PP_1985). The LeuCD holoenzyme catalyzes the reversible isomerization of (2S)‑2‑isopropylmalate to (2R,3S)‑3‑isopropylmalate, proceeding through the dehydration intermediate 2‑isopropylmaleate. This is the second of four dedicated steps of L‑leucine biosynthesis (from 2‑oxoisovalerate). The enzyme is a member of the aconitase superfamily of [4Fe‑4S] hydro‑lyases; the catalytic iron–sulfur cluster resides on LeuC, while LeuD contributes the aconitase "swivel" domain and the substrate‑binding/substrate‑discriminating loops that complete the active‑site cleft. The reaction occurs in the cytoplasm. LeuD's role is therefore that of a structural/substrate‑specificity subunit essential for isomerase activity, not a cofactor‑bearing catalytic subunit.

2. Primary Function: the Reaction Catalyzed and Substrate Specificity

Reaction (LeuCD holoenzyme):

(2S)‑2‑isopropylmalate ⇌ (2R,3S)‑3‑isopropylmalate, via 2‑isopropylmaleate (EC 4.2.1.33; Rhea RHEA:32287; ChEBI 35121 ⇌ 1178) [UniProt Q88LE7 / HAMAP MF_01031; KEGG K01704].

Mechanistically this is a dehydration followed by re‑hydration in the opposite orientation — a net isomerization achieved by a hydro‑lyase, exactly analogous to aconitase's citrate ⇌ isocitrate interconversion via cis‑aconitate. UniProt annotates the function as "Catalyzes the isomerization between 2‑isopropylmalate and 3‑isopropylmalate, via the formation of 2‑isopropylmaleate" [Q88LE7, HAMAP‑Rule MF_01031].

Experimental support for the reaction and complex comes from classical work on the enterobacterial enzyme: - IPMI "is a complex enzyme composed of two subunits which are coded for by two genes of the leucine operon, leuC and leuD … The native isopropylmalate isomerase was shown to have a Km for its substrate alpha‑isopropylmalate of 3 × 10⁻⁴ M" (Fultz & Kemper, J. Bacteriol. 1981, 7026530). - The functional complex "catalyzes the stereospecific conversion reaction of α‑isopropylmalate to β‑isopropylmalate" (Manikandan et al., 2011, 20938981).

Substrate specificity. The primary physiological substrate is 2‑isopropylmalate (the isopropyl‑substituted malate). KEGG maps ortholog K01704 to a secondary activity, EC 4.2.1.35 ((R)‑2‑methylmalate/citramalate dehydratase, C5‑branched dibasic acid metabolism, pathway ppu00660), reflecting the modest substrate promiscuity typical of aconitase‑superfamily [4Fe‑4S] hydro‑lyases toward the closely related 2‑methylmalate/citraconate. In Leptospira interrogans, the leucine‑pathway IPMI (EC 4.2.1.33) participates in a threonine‑independent isoleucine route acting on citraconate‑type substrates, directly illustrating this family flexibility (Xu et al., 2004, 15292141). The superfamily assignment is explicit: "In the aconitase superfamily, which includes the archetypical aconitase, homoaconitase, and isopropylmalate isomerase…" (Watanabe et al., 2016, 27929065).

3. Molecular Role of LeuD within the Enzyme

IPMI is an obligate heterodimer; LeuD alone is inert. Biochemical purification from Salmonella typhimurium resolved two copurifying polypeptides — 51 kDa (LeuC) and 23.5 kDa (LeuD) — and both are required, as shown by in‑vitro complementation of leuC and leuD mutant extracts (Fultz & Kemper 1981, 7026530). Genetic work confirmed that "the isopropylmalate isomerase of Salmonella typhimurium and Escherichia coli is a complex of the leuC and leuD gene products" (Stover et al., 1988, 2838459), and that a 22‑kDa LeuD functional analog (newD) can restore leucine prototrophy by pairing with LeuC (Kemper 1974, 4612005).

Division of labor: - LeuC (large subunit) harbors the catalytic [4Fe‑4S] cluster and most active‑site residues (aconitase domains 1–3). - LeuD (small subunit, this protein) supplies domain 4, the "swivel" domain of the aconitase fold. In single‑chain aconitase this domain is part of one polypeptide; in bacterial IPMI the fold is split across two genes, and LeuD reconstitutes the active‑site cleft at the LeuC–LeuD interface.

Crystallography of M. tuberculosis LeuD (to 1.2 Å) localized LeuD's two most flexible, functionally critical regions: "the regions of residues 30‑37, the substrate discriminating loop, and of residues 70‑74, the substrate binding loop" (Manikandan et al., 2011, 20938981). The same study found "the presence of two LeuD subfamilies" — consistent with the UniProt assignment of Q88LE7 to LeuD type‑1 — and showed by solution scattering that the LeuC and LeuCD shapes differ radically from mitochondrial aconitase, underscoring the distinct two‑chain architecture. Thus LeuD acts as a structural + substrate‑specificity subunit: it completes the catalytic machinery and its loops discriminate the isopropylmalate substrate, but it does not itself carry the cofactor.

4. Cofactor and Catalytic Chemistry

IPMI is a [4Fe‑4S] iron–sulfur enzyme. The cluster (on LeuC) coordinates a substrate hydroxyl/carboxylate and activates it for dehydration, exactly as in aconitase. Evidence that catalytic competence depends on Fe–S assembly: - Apo‑IPMI is activated by cluster transfer: "The assembled Fe/S cluster could be transferred from SufU to the apo form of isopropylmalate isomerase Leu1, rapidly forming catalytically active [4Fe‑4S]‑containing holo‑enzyme" (Albrecht et al., 2010, 20097860). - Impaired Fe–S biogenesis lowers IPMI activity, and IPMI is classed among "cytosolic Fe‑S enzymes (sulfite reductase and isopropylmalate isomerase)" (Patil et al., 2012, 23192348).

LeuD itself does not bind the cluster but is required to build the catalytic site around it.

5. Localization

Leucine biosynthesis in bacteria is a cytoplasmic process, and IPMI is a soluble cytoplasmic enzyme. In eukaryotes the orthologous isopropylmalate isomerase (Leu1) is explicitly described as a cytosolic Fe‑S enzyme (Patil et al., 2012, 23192348); in the prokaryote P. putida, which lacks such compartmentalization, the LeuCD complex operates in the cytoplasm. Consistent with this, UniProt Q88LE7 carries no membrane, signal‑peptide, or secretion annotation — the protein is a soluble cytoplasmic subunit.

6. Biological Pathway and Genomic Context in P. putida

Pathway placement. LeuCD catalyzes step 2 of 4 of "L‑leucine from 3‑methyl‑2‑oxobutanoate (2‑oxoisovalerate)" (UniProt PATHWAY; KEGG module M00432, "Leucine biosynthesis, 2‑oxoisovalerate ⇒ 2‑oxoisocaproate"):

1. LeuA (2‑isopropylmalate synthase) — condenses 2‑oxoisovalerate + acetyl‑CoA → 2‑isopropylmalate
2. LeuCD (this enzyme) — 2‑isopropylmalate ⇌ 3‑isopropylmalate (via 2‑isopropylmaleate)
3. LeuB (3‑isopropylmalate dehydrogenase, EC 1.1.1.85) — oxidative decarboxylation → 2‑oxoisocaproate
4. IlvE/aminotransferase — transamination → L‑leucine

KEGG also maps PP_1986 to valine/leucine/isoleucine biosynthesis (ppu00290), 2‑oxocarboxylic‑acid metabolism (ppu01210), C5‑branched dibasic acid metabolism (ppu00660), and the biosynthesis‑of‑amino‑acids map (ppu01230). This branched‑chain‑amino‑acid pathway is absent in humans, which is why IPMI is of interest as an antibacterial/antifungal target (Manikandan et al., 2011, 20938981).

Genomic organization (KEGG genome coordinates). In P. putida KT2440 the leucine genes are clustered: - leuC = PP_1985 (large subunit), 2,250,670–2,252,103 - leuD = PP_1986 (this gene), 2,252,100–2,252,744 - PP_1987, UbiE/COQ5‑family methyltransferase, 2,252,863–2,253,627 - leuB = PP_1988 (3‑isopropylmalate dehydrogenase), 2,253,682–2,254,764 - PP_1984, LysR‑family transcriptional regulator (opposite strand), upstream

Critically, leuC and leuD overlap by 4 bp (an ATGA‑type overlap), the hallmark of translational coupling that ensures the two subunits of the obligate heterodimer are produced in matched stoichiometry. The clustering of leuC–leuD with leuB mirrors the leu operon organization of enterobacteria and supports co‑regulated expression of the pathway.

Regulation (family context). In other bacteria the leuCD operon is under end‑product (branched‑chain amino acid) control — e.g., strong repression by leucine/isoleucine/valine in Streptomyces coelicolor (Craster et al., 1999, 10517590) and dedicated transcriptional regulators in mycobacteria (Rv2989/IclR‑like; Angara et al., 2018, 29523332). The LysR‑family regulator adjacent to the P. putida cluster (PP_1984) is a plausible local regulator, consistent with this general theme (inference from genomic context; not experimentally proven for P. putida).

7. Evidence That the Function Transfers to the P. putida Protein

• Sequence orthology (bioinformatic). Global Needleman–Wunsch alignment gives 67.3 % identity (134/199 aligned residues, 93 % coverage) between P. putida LeuD (Q88LE7) and experimentally characterized E. coli LeuD (P30126) — far above the ~25–30 % "twilight zone," establishing unambiguous orthology. Alignment to the M. tuberculosis crystallographic LeuD fragment gave 43.5 % identity over its length.
• Structural prediction (AlphaFold). The AlphaFold DB model AF‑Q88LE7‑F1 is highly confident (mean pLDDT 95.9; 93 % of residues >90, 0 % <50), describing a single compact swivel domain consistent with IPMI_Swivel (IPR033940). The only region of relatively reduced confidence is an N‑terminal loop (~res 30–37, homologous to the M. tuberculosis "substrate‑discriminating loop"; pLDDT ~84), independently echoing the crystallographic finding that this specificity loop is the most mobile element of LeuD, while the "substrate‑binding loop" region (~res 70–74) is highly ordered (pLDDT ~98).
• Rule‑based annotation. HAMAP family rule MF_01031 (curated, expert‑derived) assigns the reaction, pathway, subunit composition, and family.
• Experimental biochemistry (Salmonella/E. coli): subunit composition, Km, complementation (PMIDs 7026530, 2838459, 374346, 4612005).
• Structural biology (M. tuberculosis): fold, substrate loops, two subfamilies (20938981).
• Cofactor biochemistry (yeast/B. subtilis): [4Fe‑4S] requirement, cytosolic localization (PMIDs 20097860, 23192348).

8. Supported and Refuted Hypotheses

Supported: - H1 — leuD encodes the small subunit of IPMI catalyzing step 2 of leucine biosynthesis. ✅ (database + orthology + literature) - H2 — LeuD is catalytically inert alone and functions only as a LeuC–LeuD heterodimer. ✅ (PMIDs 7026530, 2838459) - H3 — The enzyme is an aconitase‑family [4Fe‑4S] cytoplasmic hydro‑lyase; cluster on LeuC, specificity loops on LeuD. ✅ (PMIDs 27929065, 20097860, 23192348, 20938981) - H4 — In P. putida, leuC/leuD are translationally coupled within a leucine gene cluster. ✅ (KEGG coordinates)

Refuted / not supported: - LeuD is not an independent catalytic enzyme, not the cofactor‑bearing subunit, and not membrane‑associated or secreted. - No evidence for a distinct "same‑symbol, different‑gene" identity — the annotation is unambiguous.

9. Limitations and Future Directions

• No P. putida‑specific enzymology. Kinetic parameters (Km, kcat), the exact stereochemistry, and the physiological reversibility have been measured in Salmonella/E. coli, not in P. putida itself; transfer is by strong orthology (67 % identity), which is highly reliable for a conserved primary‑metabolic enzyme but remains an inference.
• No experimental structure of the P. putida LeuCD complex. Structural claims derive from the M. tuberculosis LeuD crystal structure and aconitase homology; an AlphaFold model of Q88LE7 could confirm the swivel fold and loop positions.
• Regulation in P. putida is inferred from genomic context (adjacent LysR regulator; family‑wide BCAA end‑product control), not directly demonstrated.
• Secondary EC 4.2.1.35 activity is a database (KEGG) inference for the orthology group; its physiological relevance in P. putida is untested.
• Essentiality/fitness under leucine‑replete vs. minimal conditions could be confirmed with existing P. putida RB‑TnSeq datasets.

Key References

• Fultz & Kemper (1981) J. Bacteriol. PMID 7026530 — two‑subunit composition, Km.
• Stover, Kemper & Marsh (1988) PMID 2838459 — LeuC/LeuD complex; newD.
• Kemper (1974) PMID 4612005 / Fultz, Kwoh & Kemper (1979) PMID 374346 — leuC–leuD complementation, subunit substitution.
• Manikandan et al. (2011) (structural studies on LeuCD, M. tuberculosis) PMID 20938981 — crystal structure, substrate loops, subfamilies.
• Watanabe et al. (2016) PMID 27929065 — aconitase superfamily membership.
• Albrecht et al. (2010) PMID 20097860 — [4Fe‑4S] activation of IPMI.
• Patil et al. (2012) PMID 23192348 — cytosolic Fe‑S IPMI.
• Xu et al. (2004) PMID 15292141 — IPMI substrate flexibility (citraconate route).
• Angara et al. (2018) PMID 29523332; Craster et al. (1999) PMID 10517590 — leuCD operon regulation (family context).
• Databases: UniProt Q88LE7 (HAMAP MF_01031); KEGG ppu:PP_1986 / K01704 / module M00432; Rhea RHEA:32287.